Literature DB >> 25320087

Cdx1 and Cdx2 function as tumor suppressors.

Alexa Hryniuk1, Stephanie Grainger1, Joanne G A Savory1, David Lohnes2.   

Abstract

In humans, colorectal cancer is often initiated through APC loss of function, which leads to crypt hyperplasia and polyposis driven by unrestricted canonical Wnt signaling. Such polyps typically arise in the colorectal region and are at risk of transforming to invasive adenocarcinomas. Although colorectal cancer is the third most common cause of cancer-related death worldwide, the processes impacting initiation, transformation, and invasion are incompletely understood. Murine APC(Min/+) mutants are often used to model colorectal cancers; however, they develop nonmetastatic tumors confined largely to the small intestine and are thus not entirely representative of the human disease. APC(Min/+) alleles can collaborate with mutations impacting other pathways to recapitulate some aspects of human colorectal cancer. To this end, we assessed APC(Min/+)-induced polyposis following somatic loss of the homeodomain transcription factor Cdx2, alone or with a Cdx1 null allele, in the adult gastrointestinal tract. APC(Min/+)-Cdx2 mutants recapitulated several aspects of human colorectal cancer, including an invasive phenotype. Notably, the concomitant loss of Cdx1 led to a significant increase in the incidence of tumors in the distal colon, relative to APC(Min/+)-Cdx2 offspring, demonstrating a previously unrecognized role for this transcription factor in colorectal tumorigenesis. These findings underscore previously unrecognized roles for Cdx members in intestinal tumorigenesis.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  APC; Cdx; Cell Invasion; Colon Cancer; Epithelial-Mesenchymal Transition (EMT); Intestine; Invasion; Transcription; Tumor Suppressor Gene

Mesh:

Substances:

Year:  2014        PMID: 25320087      PMCID: PMC4246091          DOI: 10.1074/jbc.M114.583823

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

1.  Platelet-derived growth factor β-receptor, transforming growth factor β type I receptor, and CD44 protein modulate each other's signaling and stability.

Authors:  Helena Porsch; Merima Mehić; Berit Olofsson; Paraskevi Heldin; Carl-Henrik Heldin
Journal:  J Biol Chem       Date:  2014-05-23       Impact factor: 5.157

2.  MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells.

Authors:  J D Brown; M R DiChiara; K R Anderson; M A Gimbrone; J N Topper
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

3.  Homeosis and intestinal tumours in Cdx2 mutant mice.

Authors:  K Chawengsaksophak; R James; V E Hammond; F Köntgen; F Beck
Journal:  Nature       Date:  1997-03-06       Impact factor: 49.962

4.  Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes.

Authors:  K Takaku; M Oshima; H Miyoshi; M Matsui; M F Seldin; M M Taketo
Journal:  Cell       Date:  1998-03-06       Impact factor: 41.582

5.  Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene.

Authors:  L K Su; K W Kinzler; B Vogelstein; A C Preisinger; A R Moser; C Luongo; K A Gould; W F Dove
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

6.  A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.

Authors:  A R Moser; H C Pitot; W F Dove
Journal:  Science       Date:  1990-01-19       Impact factor: 47.728

7.  Disruption of the murine homeobox gene Cdx1 affects axial skeletal identities by altering the mesodermal expression domains of Hox genes.

Authors:  V Subramanian; B I Meyer; P Gruss
Journal:  Cell       Date:  1995-11-17       Impact factor: 41.582

Review 8.  The war on cancer.

Authors:  M B Sporn
Journal:  Lancet       Date:  1996-05-18       Impact factor: 79.321

9.  Smad3 mutant mice develop metastatic colorectal cancer.

Authors:  Y Zhu; J A Richardson; L F Parada; J M Graff
Journal:  Cell       Date:  1998-09-18       Impact factor: 41.582

10.  Key role of the Cdx2 homeobox gene in extracellular matrix-mediated intestinal cell differentiation.

Authors:  O Lorentz; I Duluc; A D Arcangelis; P Simon-Assmann; M Kedinger; J N Freund
Journal:  J Cell Biol       Date:  1997-12-15       Impact factor: 10.539

View more
  40 in total

1.  Cdx2 Regulates Gene Expression through Recruitment of Brg1-associated Switch-Sucrose Non-fermentable (SWI-SNF) Chromatin Remodeling Activity.

Authors:  Thinh T Nguyen; Joanne G A Savory; Travis Brooke-Bisschop; Randy Ringuette; Tanya Foley; Bradley L Hess; Kirk J Mulatz; Laura Trinkle-Mulcahy; David Lohnes
Journal:  J Biol Chem       Date:  2017-01-12       Impact factor: 5.157

2.  Mechanisms of colitis-accelerated colon carcinogenesis and its prevention with the combination of aspirin and curcumin: Transcriptomic analysis using RNA-seq.

Authors:  Yue Guo; Zheng-Yuan Su; Chengyue Zhang; John M Gaspar; Rui Wang; Ronald P Hart; Michael P Verzi; Ah-Ng Tony Kong
Journal:  Biochem Pharmacol       Date:  2017-03-04       Impact factor: 5.858

3.  Mismatch Repair Proteins Initiate Epigenetic Alterations during Inflammation-Driven Tumorigenesis.

Authors:  Ashley R Maiuri; Michael Peng; Ram Podicheti; Shruthi Sriramkumar; Caitlin M Kamplain; Douglas B Rusch; Christina E DeStefano Shields; Cynthia L Sears; Heather M O'Hagan
Journal:  Cancer Res       Date:  2017-05-18       Impact factor: 12.701

4.  CDX-2 Expression in Esophageal Biopsies Without Goblet Cell Intestinal Metaplasia May Be Predictive of Barrett's Esophagus.

Authors:  James Saller; Sameer Al Diffalha; Kevin Neill; Rahill A Bhaskar; Cecilia Oliveri; David Boulware; Henry Levine; Isaac Kalvaria; F Scott Corbett; Arun Khazanchi; Jason Klapman; Domenico Coppola
Journal:  Dig Dis Sci       Date:  2019-11-05       Impact factor: 3.199

5.  A novel mouse model of sporadic colon cancer induced by combination of conditional Apc genes and chemical carcinogen in the absence of Cre recombinase.

Authors:  Jeffrey S Souris; Hannah J Zhang; Urszula Dougherty; Nai-Tzu Chen; Joseph V Waller; Leu-Wei Lo; John Hart; Chin-Tu Chen; Marc Bissonnette
Journal:  Carcinogenesis       Date:  2019-11-25       Impact factor: 4.944

6.  Prognostic significance of CDX2 immunoexpression in poorly differentiated clusters of colorectal carcinoma.

Authors:  Luca Reggiani Bonetti; Simona Lionti; Enrica Vitarelli; Valeria Barresi
Journal:  Virchows Arch       Date:  2017-08-17       Impact factor: 4.064

7.  The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancer.

Authors:  Jens Neumann; Volker Heinemann; Jutta Engel; Thomas Kirchner; Sebastian Stintzing
Journal:  Virchows Arch       Date:  2018-04-19       Impact factor: 4.064

8.  Fine-tuning and autoregulation of the intestinal determinant and tumor suppressor homeobox gene CDX2 by alternative splicing.

Authors:  Camille Balbinot; Marie Vanier; Olivier Armant; Asmaa Nair; Julien Penichon; Christine Soret; Elisabeth Martin; Thoueiba Saandi; Jean-Marie Reimund; Jacqueline Deschamps; Felix Beck; Claire Domon-Dell; Isabelle Gross; Isabelle Duluc; Jean-Noël Freund
Journal:  Cell Death Differ       Date:  2017-09-01       Impact factor: 15.828

9.  Zfp703 Is a Wnt/β-Catenin Feedback Suppressor Targeting the β-Catenin/Tcf1 Complex.

Authors:  Amit Kumar; Ravindra B Chalamalasetty; Mark W Kennedy; Sara Thomas; Shreya N Inala; Robert J Garriock; Terry P Yamaguchi
Journal:  Mol Cell Biol       Date:  2016-05-31       Impact factor: 4.272

10.  CDX2 inhibits pancreatic adenocarcinoma cell proliferation via promoting tumor suppressor miR-615-5p.

Authors:  Yuanyuan Jiang; Yan Zhang; Fuqing Li; Xiaolin Du; Jinping Zhang
Journal:  Tumour Biol       Date:  2015-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.